The management of older patients with hodgkin lymphoma

Boris Böll, Andrew Evens

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Survival rates for Hodgkin lymphoma (HL) have substantially improved during the past several decades. Using stage-adapted polychemotherapy regimens and innovative radiation techniques, 5-year progression-free survival (PFS) has reached almost 90 % in young patients. Since the median age at diagnosis is approximately 32 years, these excellent results account for the majority of patients. Unfortunately, this progress has not translated into a similar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged 60 years are significantly and disproportionately inferior compared with younger patient populations.

Original languageEnglish (US)
Title of host publicationHodgkin Lymphoma
Subtitle of host publicationA Comprehensive Overview, Second Edition
PublisherSpringer International Publishing
Pages271-286
Number of pages16
ISBN (Electronic)9783319125053
ISBN (Print)9783319125046
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hodgkin Disease
Survival Rate
Combination Drug Therapy
Disease-Free Survival
Radiation
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Böll, B., & Evens, A. (2015). The management of older patients with hodgkin lymphoma. In Hodgkin Lymphoma: A Comprehensive Overview, Second Edition (pp. 271-286). Springer International Publishing. https://doi.org/10.1007/978-3-319-12505-3-15
Böll, Boris ; Evens, Andrew. / The management of older patients with hodgkin lymphoma. Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, 2015. pp. 271-286
@inbook{c20ebd087c1649f89bb1be55b263239b,
title = "The management of older patients with hodgkin lymphoma",
abstract = "Survival rates for Hodgkin lymphoma (HL) have substantially improved during the past several decades. Using stage-adapted polychemotherapy regimens and innovative radiation techniques, 5-year progression-free survival (PFS) has reached almost 90 {\%} in young patients. Since the median age at diagnosis is approximately 32 years, these excellent results account for the majority of patients. Unfortunately, this progress has not translated into a similar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged 60 years are significantly and disproportionately inferior compared with younger patient populations.",
author = "Boris B{\"o}ll and Andrew Evens",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-12505-3-15",
language = "English (US)",
isbn = "9783319125046",
pages = "271--286",
booktitle = "Hodgkin Lymphoma",
publisher = "Springer International Publishing",

}

Böll, B & Evens, A 2015, The management of older patients with hodgkin lymphoma. in Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, pp. 271-286. https://doi.org/10.1007/978-3-319-12505-3-15

The management of older patients with hodgkin lymphoma. / Böll, Boris; Evens, Andrew.

Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing, 2015. p. 271-286.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - The management of older patients with hodgkin lymphoma

AU - Böll, Boris

AU - Evens, Andrew

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Survival rates for Hodgkin lymphoma (HL) have substantially improved during the past several decades. Using stage-adapted polychemotherapy regimens and innovative radiation techniques, 5-year progression-free survival (PFS) has reached almost 90 % in young patients. Since the median age at diagnosis is approximately 32 years, these excellent results account for the majority of patients. Unfortunately, this progress has not translated into a similar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged 60 years are significantly and disproportionately inferior compared with younger patient populations.

AB - Survival rates for Hodgkin lymphoma (HL) have substantially improved during the past several decades. Using stage-adapted polychemotherapy regimens and innovative radiation techniques, 5-year progression-free survival (PFS) has reached almost 90 % in young patients. Since the median age at diagnosis is approximately 32 years, these excellent results account for the majority of patients. Unfortunately, this progress has not translated into a similar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged 60 years are significantly and disproportionately inferior compared with younger patient populations.

UR - http://www.scopus.com/inward/record.url?scp=84955705529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955705529&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12505-3-15

DO - 10.1007/978-3-319-12505-3-15

M3 - Chapter

SN - 9783319125046

SP - 271

EP - 286

BT - Hodgkin Lymphoma

PB - Springer International Publishing

ER -

Böll B, Evens A. The management of older patients with hodgkin lymphoma. In Hodgkin Lymphoma: A Comprehensive Overview, Second Edition. Springer International Publishing. 2015. p. 271-286 https://doi.org/10.1007/978-3-319-12505-3-15